Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 932 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 176-200 of 773 matching filings.

Per page
25
Current page
8
8-K File 001-35813

CURRENT REPORT

Filing date
12 Dec 2022
Reporting date
12 Dec 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
14 Nov 2022
Reporting date
13 Nov 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
10 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Oct 2022
Reporting date
27 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
19 Sep 2022
Reporting date
15 Sep 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
13 Sep 2022
Reporting date
13 Sep 2022
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
08 Sep 2022
Reporting date
01 Sep 2022
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
10 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Aug 2022
Reporting date
28 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-266105

REGISTRATION STATEMENT

Filing date
12 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
07 Jul 2022
Reporting date
07 Jul 2022
Next action
Verify source filing
DEF 14A File 001-35813

DEFINITIVE PROXY STATEMENT

Filing date
02 Jun 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
12 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
4/A

4/A filing

Filing date
10 May 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .